Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Philippa Wood"'
Autor:
Peter Tyrrell, Lauren Evans, Peadar Brehony, Philippa Wood, Rebekah Karimi, Dickson oleKaelo, Freddie Hunter, Rose Muiyuro, Esther Kang'ethe, Brian Perry
Publikováno v:
Ecological Solutions and Evidence, Vol 5, Iss 3, Pp n/a-n/a (2024)
Abstract The recent call to halt biodiversity loss by protecting half the planet has been hotly contested because of the extent to which people might be excluded from these landscapes. It is clear that incorporating landscapes that implicitly work fo
Externí odkaz:
https://doaj.org/article/df7ed4ffda2d403e9ef317ff54b0aae6
Autor:
Charlie Brincin, Dylan J. L. Payne, James Grierson, Philippa Wood, William P. Robinson, Vincenza S. Giustino, Joseph O' Sullivan, Filipo Pilati, Stavros Karydas, Ben Keeley, Steve Bright, Diego Bobis‐Villagra, Stephen Martin, Imogen Schofield, Matt Matiasovic
Publikováno v:
Veterinary Surgery. 52:379-387
Autor:
Tamar MacLellan, Philippa Wood
Publikováno v:
Axon: Creative Explorations. 11
Autor:
Philippa Wood, David Beattie, Peter M. Gillett, Thom O'Neill, Richard F.M. Chin, Deepa J Patil
Publikováno v:
O'Neill, T, Gillett, P M, Wood, P, Beattie, D, Patil, D J & Chin, R F 2021, ' Prevalence of neurological problems in a community-based sample of paediatric coeliac disease : a cross-sectional study ', Archives of Disease in Childhood . https://doi.org/10.1136/archdischild-2021-321770
BackgroundThe prevalence of and risk factors for neurological problems in childhood coeliac disease (CD) are unclear.MethodsWe performed a cross-sectional, community-based audit of CD in children diagnosed from January 2010 to December 2016 in Lothia
Autor:
Rajesh Odedra, Juliane M. Jürgensmeier, Anderson J. Ryan, Paul D. Smith, Philippa Wood, Stephen R. Wedge, Donald J. Ogilvie, Robert W. Wilkinson, Paula J. Valentine, Armelle Logie, Sharon Barnett, Jane Kendrew, Paul Elvin
Publikováno v:
Cancer Research. 70:1372-1372
Cediranib (RECENTIN™) is a highly potent vascular endothelial growth factor (VEGF) signaling inhibitor of all three VEGF receptors that is suitable for once-daily oral dosing. Cediranib is currently in Phase III development in first-line colorectal
Autor:
Williams, Glenda
Publikováno v:
Finweek. 5/5/2016, p42-43. 2p.
Autor:
Tyrrell, Peter, Evans, Lauren, Brehony, Peadar, Wood, Philippa, Karimi, Rebekah, ole Kaelo, Dickson, Hunter, Freddie, Muiyuro, Rose, Kang'ethe, Esther, Perry, Brian
Publikováno v:
Ecological Solutions & Evidence; Jul-Sep2024, Vol. 5 Issue 3, p1-16, 16p
Publikováno v:
JPGN Reports; May2024 Supplement 1, Vol. 5, pS1-S1437, 1437p
Autor:
Brincin, Charlie, Payne, Dylan J. L., Grierson, James, Wood, Philippa, Robinson, William P., Giustino, Vincenza S., O' Sullivan, Joseph, Pilati, Filipo, Karydas, Stavros, Keeley, Ben, Bright, Steve, Bobis‐Villagra, Diego, Martin, Stephen, Schofield, Imogen, Matiasovic, Matt
Publikováno v:
Veterinary Surgery; Apr2023, Vol. 52 Issue 3, p379-387, 9p
Publikováno v:
PowerTorque. Jul/Aug2024, Issue 141, p10-10. 1/3p.